过敏原免疫疗法的依从性：当前形势与未来影响。

Allergologie Select Pub Date : 2022-11-21 eCollection Date: 2022-01-01 DOI:10.5414/ALX02318E

Francesca Gehrt, Qingqing Xu, Ilaria Baiardini, Giorgio Walter Canonica, Oliver Pfaar

{"title":"过敏原免疫疗法的依从性：当前形势与未来影响。","authors":"Francesca Gehrt, Qingqing Xu, Ilaria Baiardini, Giorgio Walter Canonica, Oliver Pfaar","doi":"10.5414/ALX02318E","DOIUrl":null,"url":null,"abstract":"Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.","PeriodicalId":7485,"journal":{"name":"Allergologie Select","volume":" ","pages":"276-284"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707370/pdf/","citationCount":"0","resultStr":"{\"title\":\"Adherence in allergen immunotherapy: Current situation and future implications.\",\"authors\":\"Francesca Gehrt, Qingqing Xu, Ilaria Baiardini, Giorgio Walter Canonica, Oliver Pfaar\",\"doi\":\"10.5414/ALX02318E\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.\",\"PeriodicalId\":7485,\"journal\":{\"name\":\"Allergologie Select\",\"volume\":\" \",\"pages\":\"276-284\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707370/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Allergologie Select\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5414/ALX02318E\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologie Select","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5414/ALX02318E","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

过敏原免疫疗法（AIT）是过敏症中唯一能改变病情的治疗方法。然而，临床试验和现实生活中的研究表明，治疗依从性很差。本文旨在概述过去 10 年的最新文献，概述过敏原免疫疗法治疗依从性差的原因，并提供改善依从性的可能解决方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Adherence in allergen immunotherapy: Current situation and future implications.

Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Allergologie Select

自引率

0.00%

发文量